Intérêt d’une perfusion de diphosphonate à la phase aiguë d’un tassement vertébral ostéoporotique chez le sujet âgé
B. Godfrin(Hôpital Rangueil), P. Arlet(Hôpital Rangueil), S. Ollier(Institut universitaire du cancer de Toulouse Oncopole), Michel Laroche(Royal Bank of Canada), M. Alvarez(Hôpital Larrey), L. Sailler(Université Fédérale de Toulouse Midi-Pyrénées), C. Dingremont(Hôpital Rangueil)
Cited by 0
Related Papers
Further characterization of clinical and laboratory features in VEXAS syndrome: large‐scale analysis of a multicentre case series of 116 French patients*
|British Journal of Dermatology|2021|414
Hydroxychloroquine in systemic lupus erythematosus: results of a French multicentre controlled trial (PLUS Study)
|Annals of the Rheumatic Diseases|2012|207
Determinants of Hydroxychloroquine Blood Concentration Variations in Systemic Lupus Erythematosus
|Arthritis & Rheumatology|2015|140
Risk factors for bleeding, including platelet count threshold, in newly diagnosed immune thrombocytopenia adults
|Journal of Thrombosis and Haemostasis|2018|138